Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 4/2012

01.04.2012 | Article

Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection

verfasst von: A. Smithson, C. Chico, J. Ramos, C. Netto, M. Sanchez, J. Ruiz, R. Porron, M. T. Bastida

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to evaluate the prevalence and clinical risk factors for quinolone resistance (QR) in E. coli strains from males with febrile urinary tract infection (FUTI). An ambispective cross-sectional study was performed in which we evaluated 153 males with a community FUTI caused by E. coli. Among the 153 FUTI episodes, 101 (66%) were due to quinolone susceptible E. coli strains while 52 (34%) were caused by QR E. coli strains. In the univariate analysis QR was associated with older age, higher Charlson scores, dementia, past UTI, urinary tract abnormalities, previous antibiotic use, particularly with fluoroquinolones (FQ), a healthcare-associated (HA)-UTI (HA-UTI) and to four of the components included in the definition of HA-UTI: hospital admission, nursing home residence, indwelling urethral catheter and invasive urinary instrumentation. In the multivariate analysis, HA-UTI (OR 3.82, 95% CI 1.3–11.24; P 0.015) and use of antimicrobials in the previous month (OR 5.82, 95% CI 2.3–14.88; P < 0.001) mainly with FQ (OR 13.97, 95% CI 2.73–71.53; P 0.002) were associated with QR. To have a HA-UTI and a previous use of FQ in the preceding month were strong risk factors for QR E. coli, and thus empirical antimicrobial treatment with quinolones should be avoided in these patients.
Literatur
1.
Zurück zum Zitat Ulleryd P (2003) Febrile urinary tract infection in men. Int J Antimicrob Agents 22(Suppl 2):89–93PubMedCrossRef Ulleryd P (2003) Febrile urinary tract infection in men. Int J Antimicrob Agents 22(Suppl 2):89–93PubMedCrossRef
2.
Zurück zum Zitat Horcajada JP, Vilana R, Moreno-Martínez A, Alvarez-Vijande R, Bru C, Bargallo X, Buñesch L, Martinez JA, Mensa J (2003) Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications. Scand J Infect Dis 35:114–120PubMedCrossRef Horcajada JP, Vilana R, Moreno-Martínez A, Alvarez-Vijande R, Bru C, Bargallo X, Buñesch L, Martinez JA, Mensa J (2003) Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications. Scand J Infect Dis 35:114–120PubMedCrossRef
3.
Zurück zum Zitat Velasco M, Mateos JJ, Martínez JA, Moreno-Martinez A, Horcajada JP, Barranco M, Lomeña F, Mensa J (2004) Accurate topographical diagnosis of urinary tract infection in male patients with (111) indium-labelled leukocyte scintigraphy. Eur J Intern Med 15:157–161PubMedCrossRef Velasco M, Mateos JJ, Martínez JA, Moreno-Martinez A, Horcajada JP, Barranco M, Lomeña F, Mensa J (2004) Accurate topographical diagnosis of urinary tract infection in male patients with (111) indium-labelled leukocyte scintigraphy. Eur J Intern Med 15:157–161PubMedCrossRef
4.
Zurück zum Zitat Krieger JN, Nyberg L, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282:236–237PubMedCrossRef Krieger JN, Nyberg L, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282:236–237PubMedCrossRef
5.
Zurück zum Zitat Naber KG, Sörgel F (2003) Antibiotic therapy: rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and prostatic tissue. Andrologia 35:331–335PubMed Naber KG, Sörgel F (2003) Antibiotic therapy: rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and prostatic tissue. Andrologia 35:331–335PubMed
6.
Zurück zum Zitat Johnson L, Sabel A, Burman WJ, Everhart RM, Rome M, MacKenzie TD, Rozwadowski J, Mehler PS, Price CS (2008) Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 121:876–884PubMedCrossRef Johnson L, Sabel A, Burman WJ, Everhart RM, Rome M, MacKenzie TD, Rozwadowski J, Mehler PS, Price CS (2008) Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 121:876–884PubMedCrossRef
8.
Zurück zum Zitat Killgore KM, March KL, Guglielmo BJ (2004) Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother 38:1148–1152PubMedCrossRef Killgore KM, March KL, Guglielmo BJ (2004) Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother 38:1148–1152PubMedCrossRef
9.
Zurück zum Zitat Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group (2005) Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 56:914–918PubMedCrossRef Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group (2005) Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 56:914–918PubMedCrossRef
10.
Zurück zum Zitat Colodner R, Kometiani I, Chazan B, Raz R (2008) Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection 36:41–45PubMedCrossRef Colodner R, Kometiani I, Chazan B, Raz R (2008) Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection 36:41–45PubMedCrossRef
11.
Zurück zum Zitat Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, Strom BL (2002) Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med 162:2469–2477PubMedCrossRef Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, Strom BL (2002) Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med 162:2469–2477PubMedCrossRef
12.
Zurück zum Zitat Etienne M, Chavanet P, Sibert L, Michel F, Levesque H, Lorcerie B, Doucet J, Pfitzenmeyer P, Caron F (2008) Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect Dis 30:8–12 Etienne M, Chavanet P, Sibert L, Michel F, Levesque H, Lorcerie B, Doucet J, Pfitzenmeyer P, Caron F (2008) Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect Dis 30:8–12
13.
14.
Zurück zum Zitat Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791–797PubMed Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791–797PubMed
15.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method for classifying comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method for classifying comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef
16.
Zurück zum Zitat Lipsky BA, Ireton RC, Fihn SD, Hackett R, Berger RE (1987) Diagnosis of bacteriuria in men: specimen collection and culture interpretation. J Infect Dis 155:847–854PubMedCrossRef Lipsky BA, Ireton RC, Fihn SD, Hackett R, Berger RE (1987) Diagnosis of bacteriuria in men: specimen collection and culture interpretation. J Infect Dis 155:847–854PubMedCrossRef
17.
Zurück zum Zitat CLSI (2007) Performance Standards for antimicrobial susceptibility testing: 17th informational supplement. CLSI document M100S17. Clinical and Laboratory Standard Institute, Wayne, PA CLSI (2007) Performance Standards for antimicrobial susceptibility testing: 17th informational supplement. CLSI document M100S17. Clinical and Laboratory Standard Institute, Wayne, PA
18.
Zurück zum Zitat Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A (2008) Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 168:1897–1902PubMedCrossRef Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A (2008) Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 168:1897–1902PubMedCrossRef
19.
Zurück zum Zitat Velasco M, Horcajada JP, Mensa J, Mensa J, Moreno-Martinez A, Vila J, Martinez JA, Ruiz J, Barranco M, Roig G, Soriano E (2001) Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 33:1682–1686PubMedCrossRef Velasco M, Horcajada JP, Mensa J, Mensa J, Moreno-Martinez A, Vila J, Martinez JA, Ruiz J, Barranco M, Roig G, Soriano E (2001) Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 33:1682–1686PubMedCrossRef
20.
Zurück zum Zitat Alos JI, Serrano MG, Gomez-Garces JL, Perianes J (2005) Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect 11:199–203PubMedCrossRef Alos JI, Serrano MG, Gomez-Garces JL, Perianes J (2005) Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect 11:199–203PubMedCrossRef
21.
Zurück zum Zitat Koeijers JJ, Verbon A, Kessels AG, Bartelds A, Donkers G, Nys S, Stobberingh EE (2010) Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 76:336–340PubMedCrossRef Koeijers JJ, Verbon A, Kessels AG, Bartelds A, Donkers G, Nys S, Stobberingh EE (2010) Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 76:336–340PubMedCrossRef
22.
Zurück zum Zitat Lautenbach E, Metlay JP, Mao X, Han X, Fishman NO, Bilker WB, Tolomeo P, Wheeler M, Nachamkin I (2010) The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis 51:280–285PubMedCrossRef Lautenbach E, Metlay JP, Mao X, Han X, Fishman NO, Bilker WB, Tolomeo P, Wheeler M, Nachamkin I (2010) The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis 51:280–285PubMedCrossRef
23.
Zurück zum Zitat Hawkey PM (2003) Mechanisms of quinolone action and microbial response. J Antimicrob Chemother 51(Suppl 1):29–35PubMedCrossRef Hawkey PM (2003) Mechanisms of quinolone action and microbial response. J Antimicrob Chemother 51(Suppl 1):29–35PubMedCrossRef
24.
Zurück zum Zitat Tavio MM, Vila J, Ruiz J, Martin-Sanchez AM, Jimenez de Anta MT (1999) Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli. J Antimicrob Chemother 44:735–742PubMedCrossRef Tavio MM, Vila J, Ruiz J, Martin-Sanchez AM, Jimenez de Anta MT (1999) Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli. J Antimicrob Chemother 44:735–742PubMedCrossRef
25.
Zurück zum Zitat Poole K (2000) Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother 44:2233–2241PubMedCrossRef Poole K (2000) Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother 44:2233–2241PubMedCrossRef
26.
Zurück zum Zitat Poirel L, Cattoir V, Nordmann P (2008) Is plasmid-mediated quinolone resistance a clinically significant problem? Clin Microbiol Infect 14:295–297PubMedCrossRef Poirel L, Cattoir V, Nordmann P (2008) Is plasmid-mediated quinolone resistance a clinically significant problem? Clin Microbiol Infect 14:295–297PubMedCrossRef
27.
Zurück zum Zitat Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD (2010) Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 340:c2096. doi:10.1136/bmj.c2096 PubMedCrossRef Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD (2010) Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 340:c2096. doi:10.​1136/​bmj.​c2096 PubMedCrossRef
28.
Zurück zum Zitat Horcajada JP, Vila J, Moreno-Martínez A, Ruiz J, Martínez JA, Sánchez M, Soriano E, Mensa J (2002) Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis. J Antimicrob Chemother 49:55–59PubMedCrossRef Horcajada JP, Vila J, Moreno-Martínez A, Ruiz J, Martínez JA, Sánchez M, Soriano E, Mensa J (2002) Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis. J Antimicrob Chemother 49:55–59PubMedCrossRef
29.
Zurück zum Zitat Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O’Bryan TT, Sandberg T (2005) Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J Clin Microbiol 43:3895–3900PubMedCrossRef Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O’Bryan TT, Sandberg T (2005) Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J Clin Microbiol 43:3895–3900PubMedCrossRef
30.
Zurück zum Zitat Mazzoli S (2010) Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS Immunol Med Microbiol 59:337–344PubMed Mazzoli S (2010) Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS Immunol Med Microbiol 59:337–344PubMed
31.
Zurück zum Zitat Kadhiravan T, Wig N, Kapil A, Kabra SK, Renuka K, Misra A (2005) Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. BMC Infect Dis 5:37PubMedCrossRef Kadhiravan T, Wig N, Kapil A, Kabra SK, Renuka K, Misra A (2005) Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. BMC Infect Dis 5:37PubMedCrossRef
32.
Zurück zum Zitat Ruiz J, Gomez J, Navia MM, Ribera A, Sierra JM, Marco F, Mensa J, Vila J (2002) High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae. Diagn Microbiol Infect Dis 42:257–261PubMedCrossRef Ruiz J, Gomez J, Navia MM, Ribera A, Sierra JM, Marco F, Mensa J, Vila J (2002) High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae. Diagn Microbiol Infect Dis 42:257–261PubMedCrossRef
Metadaten
Titel
Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection
verfasst von
A. Smithson
C. Chico
J. Ramos
C. Netto
M. Sanchez
J. Ruiz
R. Porron
M. T. Bastida
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1322-y

Weitere Artikel der Ausgabe 4/2012

European Journal of Clinical Microbiology & Infectious Diseases 4/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.